Bulletin
Investor Alert

Incyte Corp.

NAS: INCY

GO
/marketstate/country/us

After Hours

/zigman2/quotes/204510994/composite

$

84.00

Change

-0.93 -1.10%

Volume

Volume 59,643

Jun 21, 2021, 5:34 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/204510994/composite

Previous close

$ 83.96

$ 84.93

Change

+0.97 +1.16%

Day low

Day high

$84.09

$85.18

Open
Open: 84.42

52 week low

52 week high

$75.52

$110.37

Open

Market cap

$18.46B

Average volume

1.20M

P/E ratio

39.21

Rev. per Employee

$1.50M

EPS

2.17

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/incy

MarketWatch News on INCY

  1. Incyte Corp. stock rises Monday, still underperforms market

    5:00 p.m. June 21, 2021

    - MarketWatch Automation

  2. Incyte Corp. stock outperforms market on strong trading day

    5:00 p.m. June 18, 2021

    - MarketWatch Automation

  3. Incyte Corp. stock outperforms market on strong trading day

    5:00 p.m. June 16, 2021

    - MarketWatch Automation

  4. 5 Undervalued Healthcare Stocks

    11:54 a.m. June 16, 2021

    - Barron's Online

  5. Incyte Corp. stock outperforms market on strong trading day

    5:00 p.m. June 15, 2021

    - MarketWatch Automation

  6. Incyte Corp. stock rises Monday, still underperforms market

    5:00 p.m. June 14, 2021

    - MarketWatch Automation

  7. Incyte Corp. stock underperforms Friday when compared to competitors

    5:00 p.m. June 11, 2021

    - MarketWatch Automation

  8. Incyte Corp. stock falls Tuesday, underperforms market

    5:00 p.m. June 8, 2021

    - MarketWatch Automation

  9. Incyte Corp. stock rises Monday, outperforms market

    5:00 p.m. June 7, 2021

    - MarketWatch Automation

  10. Incyte Corp. stock rises Friday, still underperforms market

    5:00 p.m. June 4, 2021

    - MarketWatch Automation

  11. Incyte Corp. stock outperforms competitors on strong trading day

    5:00 p.m. June 3, 2021

    - MarketWatch Automation

  12. Incyte Corp. stock underperforms Wednesday when compared to competitors

    5:00 p.m. June 2, 2021

    - MarketWatch Automation

  13. Incyte Corp. stock underperforms Tuesday when compared to competitors

    5:00 p.m. June 1, 2021

    - MarketWatch Automation

  14. Incyte Corp. stock rises Friday, outperforms market

    5:00 p.m. May 28, 2021

    - MarketWatch Automation

  15. Incyte Corp. stock outperforms competitors despite losses on the day

    5:01 p.m. May 27, 2021

    - MarketWatch Automation

  16. Incyte Corp. stock outperforms competitors on strong trading day

    5:00 p.m. May 26, 2021

    - MarketWatch Automation

  17. Loading more headlines...
/news/nonmarketwatch/company/us/incy

Other News on INCY

  1. Wall Street Breakfast: The Week Ahead

    7:03 a.m. June 20, 2021

    - Seeking Alpha

  2. How This Pharma Company Can Benefit From Its Competitors

    5:11 a.m. June 20, 2021

    - Motley Fool

  3. Seeking Alpha Catalyst Watch

    3:30 p.m. June 18, 2021

    - Seeking Alpha

  4. Leerink Partners Sticks to Its Sell Rating for Incyte (INCY)

    1:56 a.m. June 15, 2021

    - SmarterAnalyst

  5. REGN vs. INCY: Which Stock Should Value Investors Buy Now?

    11:40 a.m. June 11, 2021

    - Zacks.com

  6. Incyte: Slowly Moving Along

    1:16 p.m. May 24, 2021

    - Seeking Alpha

  7. Incyte's vitiligo treatment meets late-stage trial main goal

    7:37 a.m. May 17, 2021

    - Seeking Alpha

  8. Oppenheimer Sticks to Their Buy Rating for Incyte (INCY)

    9:25 p.m. May 4, 2021

    - SmarterAnalyst

  9. 10-Q: INCYTE CORP

    4:18 p.m. May 4, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  10. Loading more headlines...
/news/pressrelease/company/us/incy

Press Releases on INCY

  1. S&P 500 Movers: VRTX, FCX

    11:18 a.m. June 11, 2021

    - MarketNewsVideo.com

  2. Nasdaq 100 Movers: VRTX, PTON

    11:17 a.m. June 11, 2021

    - MarketNewsVideo.com

  3. Loading more headlines...

Rates »

Link to MarketWatch's Slice.